Dr. Anath Shalev, renowned diabetes researcher and Chief Scientific Officer of TIXiMED, Inc., a company dedicated to the development and commercialization of TXNIP inhibiting medications, presented her work on verapamil and TXNIP inhibition at the 2023 Immunology of Diabetes Society Congress in Paris.BIRMINGHAM, Ala.
New Books by NER Authors nereview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nereview.com Daily Mail and Mail on Sunday newspapers.
Fall 2022 Announcements: Memoirs & Biographies publishersweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from publishersweekly.com Daily Mail and Mail on Sunday newspapers.